# SOFTWARE LICENSE AGREEMENT
## CriOS Discovery Engine - Enterprise Edition

**Effective Date**: [DATE]

**Between**:
- **Crowe BioSystems, Inc.** ("Licensor")
- **[PHARMACEUTICAL COMPANY NAME]** ("Licensee")

---

## 1. DEFINITIONS

1.1 **"Software"** means the CriOS Discovery Engine platform, including all modules, APIs, documentation, and updates.

1.2 **"Authorized Users"** means employees and contractors of Licensee permitted to access the Software.

1.3 **"Confidential Information"** means any proprietary information disclosed by either party.

1.4 **"Discoveries"** means any compounds, molecules, or drug candidates identified using the Software.

1.5 **"Territory"** means [SPECIFY: worldwide, specific regions, etc.]

---

## 2. GRANT OF LICENSE

2.1 **License Grant**: Licensor grants Licensee a non-exclusive, non-transferable license to use the Software for drug discovery and development purposes within the Territory.

2.2 **Scope of Use**:
- Unlimited compound processing
- Up to [NUMBER] Authorized Users
- [On-premise/Cloud/Hybrid] deployment
- Access to all Software modules specified in Exhibit A

2.3 **Restrictions**: Licensee shall not:
- Reverse engineer or decompile the Software
- Sublicense or redistribute the Software
- Use for non-pharmaceutical applications without permission
- Remove proprietary notices

---

## 3. INTELLECTUAL PROPERTY

3.1 **Software Ownership**: Licensor retains all rights to the Software and improvements thereof.

3.2 **Discovery Ownership**: Licensee owns all Discoveries made using the Software.

3.3 **Feedback License**: Licensee grants Licensor a perpetual, royalty-free license to use feedback for Software improvements.

3.4 **Joint Developments**: Any jointly developed features shall be owned as specified in separate agreements.

---

## 4. FEES AND PAYMENT

4.1 **License Fee**: $[AMOUNT] per year

4.2 **Payment Terms**: 
- Annual payment due within 30 days of invoice
- Late payments subject to 1.5% monthly interest

4.3 **Additional Services**:
- Custom model development: $[AMOUNT]/model
- Additional training: $[AMOUNT]/day
- Priority support: $[AMOUNT]/month

---

## 5. SERVICES AND SUPPORT

5.1 **Implementation**: Licensor will provide:
- Installation and configuration
- Data migration assistance
- Initial training for up to [NUMBER] users
- 90-day implementation support

5.2 **Ongoing Support**:
- 24/7 technical support for critical issues
- Business hours support for standard issues
- Quarterly business reviews
- Annual on-site training

5.3 **Updates**: All Software updates and new features included at no additional cost.

---

## 6. SERVICE LEVEL AGREEMENT

6.1 **Availability**: 99.9% uptime guaranteed (excluding scheduled maintenance)

6.2 **Response Times**:
- Critical issues: 1 hour
- High priority: 4 hours
- Medium priority: 24 hours
- Low priority: 72 hours

6.3 **Credits**: Service credits for downtime as specified in Exhibit B.

---

## 7. DATA SECURITY AND PRIVACY

7.1 **Security Standards**: Licensor maintains:
- SOC 2 Type II certification
- HIPAA compliance
- End-to-end encryption
- Regular security audits

7.2 **Data Ownership**: Licensee owns all data processed through the Software.

7.3 **Data Processing**: Licensor processes data solely for providing Services.

7.4 **Breach Notification**: Notification within 72 hours of any security breach.

---

## 8. CONFIDENTIALITY

8.1 **Obligations**: Each party shall:
- Maintain confidentiality for 5 years
- Use Confidential Information solely for Agreement purposes
- Protect with same degree of care as own information

8.2 **Exceptions**: Standard exceptions for publicly known, independently developed, or legally required disclosures.

---

## 9. WARRANTIES AND DISCLAIMERS

9.1 **Licensor Warranties**:
- Software will perform materially as documented
- Services will be performed professionally
- No known harmful code

9.2 **Disclaimers**: 
- NO WARRANTY OF FITNESS FOR PARTICULAR PURPOSE
- NO WARRANTY THAT DISCOVERIES WILL BE SUCCESSFUL
- NO REGULATORY APPROVAL GUARANTEES

---

## 10. INDEMNIFICATION

10.1 **Licensor Indemnification**: Against third-party IP infringement claims regarding the Software.

10.2 **Licensee Indemnification**: Against claims arising from:
- Use of Discoveries
- Violation of Agreement terms
- Negligent or wrongful acts

10.3 **Procedure**: Standard notice and cooperation requirements.

---

## 11. LIMITATION OF LIABILITY

11.1 **Cap**: Total liability limited to fees paid in prior 12 months.

11.2 **Exclusions**: No liability for:
- Indirect or consequential damages
- Lost profits or revenues
- Failed drug development

11.3 **Exceptions**: Excludes breaches of confidentiality, indemnification obligations, and willful misconduct.

---

## 12. TERM AND TERMINATION

12.1 **Term**: Three (3) years from Effective Date.

12.2 **Renewal**: Automatic annual renewal unless 90-day notice.

12.3 **Termination for Cause**: 30-day cure period for material breach.

12.4 **Effect of Termination**:
- License rights cease
- Data export provided within 30 days
- Confidentiality survives
- Discoveries remain with Licensee

---

## 13. COMPLIANCE AND AUDIT

13.1 **Regulatory Compliance**: Software complies with:
- FDA 21 CFR Part 11
- EMA guidelines
- ICH standards

13.2 **Audit Rights**: Annual audit with 30-day notice.

13.3 **Export Control**: Compliance with all export regulations.

---

## 14. SPECIAL PROVISIONS

14.1 **Ethical Use**: Licensee agrees to:
- Use Software for beneficial medical purposes
- Comply with ethics screening recommendations
- Not develop harmful or controversial compounds

14.2 **Publication Rights**: Licensee may publish with appropriate confidentiality.

14.3 **Reference Rights**: Mutual agreement required for public references.

---

## 15. GENERAL PROVISIONS

15.1 **Governing Law**: Laws of [Delaware/New York/etc.]

15.2 **Dispute Resolution**: 
- Good faith negotiation (30 days)
- Mediation (60 days)
- Binding arbitration (AAA rules)

15.3 **Entire Agreement**: Supersedes all prior agreements.

15.4 **Amendment**: Written agreement required.

15.5 **Assignment**: Consent required except for affiliates/successors.

15.6 **Force Majeure**: Standard provisions.

15.7 **Severability**: Invalid provisions severable.

15.8 **Notices**: Written notice to designated addresses.

---

## SIGNATURE PAGE

**LICENSOR: Crowe BioSystems, Inc.**

By: _______________________________
Name: Dr. Michael Crowe
Title: Chief Executive Officer
Date: _____________________________

**LICENSEE: [COMPANY NAME]**

By: _______________________________
Name: _____________________________
Title: ____________________________
Date: _____________________________

---

## EXHIBIT A: LICENSED MODULES

### Core Platform
- [ ] CriOS Discovery Engine Base
- [ ] Crowe Scoring Framework
- [ ] Ethics Screening Module
- [ ] Real-time Validation API

### Advanced Modules
- [ ] Custom Model Training
- [ ] Federated Learning
- [ ] Quantum Computing Interface
- [ ] Clinical Prediction Module

### Therapeutic Area Modules
- [ ] Oncology Optimization
- [ ] Neurodegeneration Suite
- [ ] Infectious Disease Platform
- [ ] Rare Disease Finder

### Integration Modules
- [ ] ELN Connector
- [ ] LIMS Integration
- [ ] Database Synchronization
- [ ] Cloud Storage Interface

---

## EXHIBIT B: SERVICE LEVEL CREDITS

| Monthly Uptime | Service Credit |
|----------------|----------------|
| 99.9% - 99.99% | 0% |
| 99.0% - 99.89% | 5% |
| 98.0% - 98.99% | 10% |
| 97.0% - 97.99% | 20% |
| Below 97.0% | 30% |

Maximum monthly credit: 30% of monthly fee

---

## EXHIBIT C: SUPPORT TIERS

### Priority Levels

**Critical (P1)**:
- Production system down
- No workaround available
- Response: 1 hour

**High (P2)**:
- Major functionality impaired
- Business impact
- Response: 4 hours

**Medium (P3)**:
- Minor functionality issue
- Workaround available
- Response: 24 hours

**Low (P4)**:
- Questions or enhancements
- No immediate impact
- Response: 72 hours

---

## EXHIBIT D: DATA PROCESSING ADDENDUM

[Detailed GDPR/HIPAA compliance terms]

---

## EXHIBIT E: PROFESSIONAL SERVICES

### Implementation Services
- Project management
- System configuration
- Data migration
- Integration setup
- User training
- Go-live support

### Ongoing Services
- Quarterly optimization
- Annual architecture review
- Custom model development
- Algorithm enhancement

---

*End of Agreement*